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The SPI-2 type III secretion system (T3SS) of intracel-
lular Salmonella enterica translocates effector
proteins into mammalian cells. Infection of antigen-
presenting cells results in SPI-2 T3SS-dependent
ubiquitination and reduction of surface-localized
mature MHC class II (mMHCII). We identify the
effector SteD as required and sufficient for this
process. In Mel Juso cells, SteD localized to the
Golgi network and vesicles containing the E3 ubiqui-
tin ligase MARCH8 and mMHCII. SteD caused
MARCH8-dependent ubiquitination and depletion
of surface mMHCII. One of two transmembrane do-
mains and the C-terminal cytoplasmic region of
SteD mediated binding to MARCH8 and mMHCII,
respectively. Infection of dendritic cells resulted in
SteD-dependent depletion of surface MHCII, the
co-stimulatory molecule B7.2, and suppression of
T cell activation. SteD also accounted for suppres-
sion of T cell activation during Salmonella infection
of mice. We propose that SteD is an adaptor, forcing
inappropriate ubiquitination of mMHCII by MARCH8
and thereby suppressing T cell activation.
INTRODUCTION
Major histocompatibility complex class II (MHCII) molecules
have a pivotal function in adaptive immunity by displaying anti-
genic peptides on the surface of antigen-presenting cells such
as dendritic cells (DCs) to CD4-restricted T cells, leading to
their activation, proliferation, and differentiation. MHCII com-
plexes consist of heterodimers of a and b chains that assemble
in the endoplasmic reticulum (ER) along with the chaperone
invariant chain (Ii) to form a larger structure called the immature
MHCII complex (Ii-MHCII). This complex migrates through584 Cell Host & Microbe 20, 584–595, November 9, 2016 ª 2016 The
This is an open access article under the CC BY license (http://creativethe Golgi network to the plasma membrane and a late endoso-
mal MHCII compartment, where Ii is degraded by lysosomal
proteases, leaving the CLIP peptide in the MHCII peptide-
binding groove of the a/b heterodimer. Class II related chaper-
ones HLA-DM and HLA-DO exchange CLIP for antigenic
peptides to form mature MHCII (mMHCII) complexes. These
are transported to the cell surface for antigen presentation
(Neefjes et al., 2011). Surface-localized mMHCII can undergo
internalization and recycling back to the plasma membrane
(Roche and Furuta, 2015). In immature DCs, the E3 ligase
MARCH1 ubiquitinates internalized mMHCII, leading to its
incorporation into multivesicular bodies and lysosomal degra-
dation (Cho et al., 2015). Activation of DCs is accompanied
by reduced expression of MARCH1, enabling internalized
mMHCII to recycle back to the plasma membrane (De Gassart
et al., 2008).
After oral ingestion, Salmonella enterica encounters DCs in
Peyer’s patches of the small intestine (Tam et al., 2008).
Following uptake by DCs, the majority of bacteria remain within
a membrane bound compartment, the Salmonella-containing
vacuole (SCV), from where they deliver effector proteins to the
host cell via the SPI-2 type III secretion system (T3SS) (Jantsch
et al., 2003).
It has been known for over a decade that Salmonella inhibits
the process of antigen presentation by mMHCII molecules in
DCs (Cheminay et al., 2005; Halici et al., 2008; Jackson et al.,
2013; Lapaque et al., 2009a; Mitchell et al., 2004; Tobar et al.,
2004, 2006). This is dependent on a functional SPI-2 T3SS
(Cheminay et al., 2005; Mitchell et al., 2004). Mutant strain anal-
ysis showed that several effectors affecting vesicular trafficking
disrupt T cell proliferation (Cheminay et al., 2005; Halici et al.,
2008). Another study revealed that in Salmonella-infected cells,
surface levels of mMHCII are reduced through its ubiquitination
(Jackson et al., 2013; Lapaque et al., 2009a). However, the effec-
tor(s) and mechanisms involved in the regulation of mMHCII
ubiquitination are unknown.
Here, we show that SteD is a SPI-2 T3SS effector that
is required and sufficient for depletion of mMHCII from
the surface of infected cells. Further work showed that SteDAuthors. Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
Figure 1. Salmonella SPI-2 T3SS Effector
SteD Reduces Surface Levels of Mature
MHCII Molecules
(A) Mel Juso cells were infected with WT or mutant
Salmonella strains for 16 hr and surface levels of
mMHCII were measured by flow cytometry using
mAb L243 (that specifically recognizes mature
HLA-DR). The error bars represent SD of the
geometric mean fluorescence of two independent
experiments performed in duplicate.
(B) Representative FACS plots showing surface
levels of mMHCII in infected cells (i) compared to
uninfected cells (ui). The histograms show surface
levels of mMHCII in infected (i, blue) and unin-
fected (ui, dark gray) cells. The cells labeled with
isotype control antibody are shown in light gray.
(C) Mel Juso cells were infected with DsteD strain
carrying pWSK29, expressing SteD-2HA regu-
lated by its endogenous promoter (psteD). The
infected and uninfected cells were discriminated
using anti-Salmonella CSA-1 antibody after fixa-
tion. The data represent surface levels of mMHCII
in infected cells as a percentage of those in unin-
fected cells from the same sample.
(D) Mel Juso cells were transfected with vectors
encoding GFP-tagged effectors, andmMHCII was
analyzed by flow cytometry. The data represent
surface levels of mMHCII in transfected cells as a
percentage of those in untransfected cells from
the same sample.
(C and D) Error bars represent SD of the geometric
mean fluorescence of three experiments done in
duplicate and were analyzed through comparison
with WT Salmonella (C) or GFP-only transfected
cells (D) by one-way ANOVA followed byDunnett’s
multiple comparison test. ***p < 0.001, **p < 0.01,
*p < 0.05, and not significant, ns.is an integral membrane protein that interacts with the
E3 ubiquitin ligase MARCH8 and mMHCII. SteD stimulates
MARCH8-mediated ubiquitination of the b chain of mMHCII
and accounts for the ability of Salmonella to inhibit T cell
responses.
RESULTS
SteD Reduces Surface Levels of mMHCII
To identify Salmonella SPI-2 T3SS effector(s) involved in the
removal of mMHCII molecules from the surface of infected cells,
we used a collection of mCherry-expressing mutant strains lack-
ing individual SPI-2 T3SS effectors to infect human Mel Juso
cells. This cell line is widely used to studyMHC class II traffickingCell Host & Miand presentation. Three human MHCII
isotypes exist: HLA-DR, HLA-DQ, and
HLA-DP. mMHCII surface levels were
measured by flow cytometry using mAb
L243, which recognizes mature HLA-DR
(Bijlmakers et al., 1994). Of the panel
of 33 single mutants, a double, and a tri-
ple mutant, all strains reduced surface
mMHCII to approximately the same
degree as the wild-type (WT) strain, withthe exception of DssaV, DsifA, and DsteD strains (Figure 1A).
SsaV is an essential component of the SPI-2 secretion appa-
ratus, and its absence prevents bacteria from translocating all
T3SS effectors. Vacuoles harboring DsifA bacteria are unstable,
whereas the majority of vacuoles containing DsifA/DsopD2 bac-
teria remain intact (Schroeder et al., 2010). The surface levels of
mMHCII in cells infected with the DsifA/DsopD2 mutant were
similar to those caused by the WT strain, suggesting that the ef-
fect of the DsifAmutant is likely to be indirect, resulting from loss
of the vacuolar membrane. We created a second steD deletion
mutant expressing GFP and tested its effect on surface levels
of mMHCII in infected Mel Juso cells. There was a reduction of
mMHCII in cells infected with GFP-expressing WT bacteria
(Figure 1B, i) compared to uninfected cells (Figure 1B, ui), butcrobe 20, 584–595, November 9, 2016 585
no difference was detected in DssaV or DsteD infected cells
(Figure 1B, i) compared to uninfected cells in the same sample
(Figure 1B, ui). To establish if the lack of effect of DsteD on
mMHCII was due to the absence of steD and not to an adventi-
tious mutation or polar effect, the mutant strain was transformed
with a low copy number plasmid (pWSK29) encoding SteD-2HA
under the control of its endogenous promoter. This strain (DsteD
psteD) removed surface mMHCII to the same extent as the WT
strain (Figures 1C and S5A). The WT strain carrying psteD-2HA
further reduced mMHCII surface levels (Figure 1C). The similar
phenotypes of the DsteD and DssaV mutants suggest that
SteD accounts for all of the SPI-2 T3SS-mediated effect.
Furthermore, ectopic expression of GFP-tagged SteD or SifA
in Mel Juso cells showed that SteD specifically reduced mMHCII
from the cell surface in the absence of other SPI-2 effectors (Fig-
ures 1D and S5B). From these experiments, we conclude that
SteD is required and sufficient for the reduction of surface levels
of mMHCII in Mel Juso cells.
Localization and Topology of SteD
SPI-2 T3SS-dependent translocation of SteD was shown using
CyaA reporter fusions (Niemann et al., 2011). steD is present in
the genome of several serovars of S. enterica, including S. Typhi-
murium, S. Enteritidis, S. Gallinarum, S. Paratyphi, and S. Typhi
(Figure S1A). No similarity of predicted amino acid sequences to
proteins of any other bacterial genera was found by BLAST
analysis.
To determine the subcellular localization of SteD after its trans-
location or ectopic expression, we infected Mel Juso cells with
Salmonella DsteD psteD-2HA or transfected cells with a plasmid
encoding GFP-SteD. Immunofluorescencemicroscopy revealed
that SteD accumulated in the region of the Golgi network, as
shown by co-localization with the trans-Golgi network (TGN) pro-
tein TGN46 (Figure S1B). Translocation of SteD-2HA from bacte-
ria depended on a functional SPI-2 T3SS (Figure S1C). To test
if SteD localizes to Golgi membranes, Mel Juso cells were
exposed to Brefeldin A (BFA) to disassemble the Golgi network,
and the localization of SteD was examined by immunofluores-
cence microscopy together with cis- and TGN proteins GM130
and TGN46, respectively (Figure S1D). Along with TGN46 and
GM130, SteD dispersed after exposure of cells to BFA. Further-
more, SteD relocalized to a reformed Golgi network 90 min after
BFA washout (Figure S1D). There was significantly greater co-
localization between SteD and TGN46 than with GM130 (Fig-
ure S1B, right), indicating that it accumulates predominantly in
the TGN. Live cell imaging analysis of Mel Juso cells expressing
GFP-SteD revealed that the majority of effector remained clus-
tered and relatively immobile (consistent with TGN localization).
However, a second pool of SteD was also observed in tubular/
vesicular structures that were highly dynamic, moving exten-
sively throughout cells in anterograde and retrograde directions
(Movie S1).
SteD is a small protein comprising 111 amino acids (12 kDa)
and is predicted by TMHMM v2.0 software (Krogh et al., 2001) to
be an integral membrane protein (Figure 2A). To test this exper-
imentally, Mel Juso cells were infected with DsteD psteD-2HA
Salmonella and subjected to membrane fractionation. Using
calreticulin (CALR) andGolgin 97 as controls for peripheral mem-
brane proteins and TGN46 as an integral membrane protein,586 Cell Host & Microbe 20, 584–595, November 9, 2016western blot analysis revealed that SteD was highly enriched
in the fraction comprising transmembrane proteins (Fig-
ure 2B). To establish the topology of SteD, we used C-terminal
HA-tagged effector translocated by the bacteria (DsteD psteD-
2HA) and N-terminal FLAG-tagged effector (FLAG-SteD) ectop-
ically expressed in Mel Juso cells in membrane permeabilization
experiments. Both N- and C-terminal epitope tags were de-
tected after selective permeabilization of the plasma membrane
with digitonin (Figure 2C), showing that SteD has two transmem-
brane regions and that both the N- and C-termini are exposed
to the host cell cytosol (Figure 2D).
SteD Reduces Surface Levels of mMHCII by Increasing
Ubiquitination of Residue K225 on the Cytoplasmic Tail
of the b Chain
To determine if SteD affects the internalization and recycling pro-
cess of surface-localized mMHCII, Mel Juso cells were infected
with WT or DsteD mutant bacteria and then incubated with un-
conjugated mAb L243 on ice for 30 min to label surface mMHCII.
Subsequently, cells were washed and transferred to 37C to
reinitiate internalization/recycling and the amount of mMHCII
remaining on the surface at different time points was analyzed
by incubating cells with an Alexa Fluor-conjugated secondary
antibody to mAb L243 and flow cytometry. In agreement with
previous results (Lapaque et al., 2009a), WT Salmonella-infected
cells underwent a greater rate of loss of surface mMHCII
compared to uninfected cells; however, this difference was not
observed when cells were infected with the DsteD strain (Fig-
ure 3A). Confocal immunofluorescence microscopy of cells at
the 4 hr time point revealed intracellular mMHCII in cells infected
by WT Salmonella and DsteD psteD strains, but not in cells
infected by the DsteD mutant (Figure 3B, Y-Z planes). These
results show that SteD affects cell surface internalization and/
or recycling of mMHCII.
Salmonella induces ubiquitination of a lysine residue (K225) in
the cytosolic tail of the DRb chain, and K225 is required for
reduction of surface levels of mMHCII by Salmonella (Lapaque
et al., 2009a). To investigate the involvement of SteD in this
process, ubiquitination of mMHCII in infected cells and in cells
stably expressing GFP or GFP-SteD was examined by immuno-
precipitation of mMHCII and immunoblotting. Immunoprecipi-
tates from cells infected byWT or DsteD psteD strains contained
ubiquitinated protein(s) whose levels were reduced or absent in
cells infected by DssaV and DsteD strains (Figure 3C). Stable
expression of GFP-SteD in Mel Juso cells also led to ubiquitina-
tion of immunoprecipitated protein(s) (Figure 3D). An anti-HA
antibody was then employed to immunoprecipitate HA-tagged
DRb (either wild-type [HA-DRb] or a mutant in which K225 was
substituted with arginine [HA-DRb K225R]) from Mel Juso cells
stably expressing these constructs. There was an increase in
ubiquitination of immunoprecipitated protein(s) in cells express-
ing GFP-SteD and HA-DRb (DRb/SteD) compared to cells lack-
ing SteD (DRb) (Figure 3E). The size of the most prominent band
corresponds to di-ubiquitinated DRb. No such SteD-dependent
increase in ubiquitinated proteins was detected in immunopre-
cipitates from cells expressing HA-DRb K225R, indicating that
K225 is the target of SteD-induced ubiquitination (Figure 3E).
The total surface content of mMHCII in these cells could
comprise both endogenous and HA-tagged proteins. There
Figure 2. SteD Is an Integral Membrane
Protein and Both the N- and C-termini Are
Exposed to the Host Cell Cytosol
(A) Amino acid sequence of SteD showing trans-
membrane domains (TMD) predicted by TMHMM
2.0 software shaded in gray.
(B) Membrane fractionation of Mel Juso cells in-
fected for 20 hr with DsteD psteD-2HA. The solu-
ble proteins were separated from total membrane
proteins, which were later treated with 2.5 M urea
to discriminate between the integral membrane
and membrane-associated proteins by ultracen-
trifugation. Calreticulin (CALR) and Golgin 97 are
membrane-associated proteins and TGN46 is an
integral Golgi membrane protein.
(C) Mel Juso cells were infected with DsteD psteD-
2HA (top two panels) or transfected with vector
encoding SteD fused at its N terminus to FLAG
epitope (FLAG-SteD) (bottom two panels). The
cells were semi- or completely permeabilized with
digitonin or Triton X-100 to discriminate between
cytoplasmic and Golgi luminal antigens, respec-
tively. The antibodies recognizing the luminal
portion of TGN46 or cytoplasmic GM130 were
used as controls. The scale bar represents 5 mm.
(D) Schematic representation of SteD topology
in the membrane (Protter 1.0 software; Omasits
et al., 2014).was no detectable difference in surface mMHCII (using mAb
L243) between cells expressing endogenous proteins together
with HA-DRb or HA-DRb K225R in the absence of SteD (Fig-
ure 3F), presumably reflecting a low turnover in these cells.
SteD reduced surface mMHCII levels by approximately 90% in
cells expressing HA-DRb, but only by approximately 70% in cells
expressing HA-DRb K225R (Figures 3F and S5C). This shows
that HA-DRb K225R is at least partially resistant to SteD-depen-
dent modification and suggests that the reduction of surface
mMHCII in HA-DRb K225R-expressing cells is due to the action
of SteD on endogenous mMHCII.
SteD Interacts with MARCH8 and mMHCII
The amino acid sequence of SteD does not suggest an enzy-
matic activity or other function that would explain the ubiquitina-
tion of mMHCII. Therefore, we hypothesized that the enzyme
causing SteD-dependent mMHCII ubiquitination was likely to
be derived from the host cell. Two highly related members ofCell Host & Mithe MARCH family of E3 integral mem-
brane ubiquitin ligases (MARCH1 and
MARCH8, which share 79.4% similarity;
Fujita et al., 2013) reduce surface levels
of mMHCII when overexpressed in
Mel Juso cells (Lapaque et al., 2009b).
MARCH1 is expressed in immature DCs
and its expression is downregulated
upon DC activation, leading to stabiliza-
tion of mMHCII on the cell surface
(De Gassart et al., 2008). In contrast,
MARCH8 is expressed in a broad range
of cell types, including Mel Juso cells
(van de Kooij et al., 2013). However, MelJuso cells do not express MARCH1 (Lapaque et al., 2009a).
Therefore, we used small interfering (si)RNA to deplete MARCH8
and analyzed the ability of Salmonella to reduce surface levels
of mMHCII in these cells (Figures 4A and S5D). Depletion of
MARCH8, but not MARCH9 (Figure S2A), impaired the capacity
ofWTSalmonella to reduce surface levels of mMHCII (Figure 4A).
In addition, infection of Mel Juso cells in which MARCH8
was depleted by small hairpin (sh)RNA (Figure S2B) revealed
that SteD-dependent mMHCII ubiquitination requires MARCH8
(Figure 4B).
To investigate if SteD interacts with MARCH8, HEK293T cells
(which do not express mMHCII) were transfected with plasmids
encoding MARCH8-FLAG and GFP-SteD, then subjected to
immunoprecipitation with GFP-Trap beads. MARCH8-FLAG
co-immunoprecipitated with GFP-SteD, but not with GFP alone
(Figure 4C). Immunofluorescencemicroscopy of transfectedMel
Juso cells revealed that MARCH8-FLAG frequently co-localized
with mMHCII in distinct vesicles (Figure 4D). These vesicles alsocrobe 20, 584–595, November 9, 2016 587
Figure 3. SteD Depletes Surface Levels of
mMHCII and Increases Its Ubiquitination
(A) Flow cytometry analysis showing surface
mMHCII in Mel Juso cells infected with WT-GFP
or DsteD-GFP strains compared to uninfected
cells. The cells were infected for 16 hr and then
labeled with mAb L243 on ice for 30 min to block
internalization. The cells were exposed to 37C to
enable resumption of internalization. The surface
levels of mMHCII at various time points were
normalized to those at the time of transfer to 37C
(0 min), which represents 100%.
(B) Cells at 16 hr post invasion were labeled with
mAb L243 on ice and incubated for another 4 hr
in complete medium at 37C. The cells were
fixed and processed for immunofluorescence
microscopy with DAPI nuclear stain (blue), anti-
Salmonella CSA-1 (green), and anti-mouse sec-
ondary antibody against L243 (red). The images
are maximum intensity Z projections showing the
difference in mMHCII surface levels between
cells infected with WT or DsteD psteD and its
intracellular accumulation (arrows). The scale bar
represents 5 mm. The regions indicated by white
dashed lines of Z projections are shown below in
the YZ plane. The internalized mMHCII in cells
infected with WT or DsteD psteD strains are
indicated by arrowheads.
(C) Mel Juso cells were infected at an MOI of
300:1 and at 16 hr post invasion lysed for immu-
noprecipitation with mAb L243 followed by
western blot analysis with anti-ubiquitin (P4D1-
HRP), anti-DRa, and anti-b tubulin antibodies.
(D) Stable Mel Juso cell lines expressing GFP or
GFP-SteD were lysed and mAb L243 or IgG2a
isotype control was used for immunoprecipita-
tion. The immunoprecipitates were analyzed by
western blot with the same antibodies as in (C).
(E) HA-tagged DRb constructs (either wild-type
[HA-DRb] or with an arginine substitution of lysine
225 on DRb cytoplasmic tail [HA-DRb K225R])
were used to transduce Mel Juso cells or stable
cells expressing GFP-SteD. The cells were lysed
and immunoprecipitated with anti-HA antibody
coupled to agarose beads followed by western
blot analysis with anti-HA, anti-ubiquitin (P4D1-
HRP), and anti-b tubulin antibodies. The blot
shown is representative of three separate ex-
periments in which band intensities, normalized
to corresponding HA bands, are 1.00 ± 0.02
(DRb), 0.59 ± 0.06 (DRbK225), 1.42 ± 0.44 (DRb/
SteD), and 0.50 ± 0.13 (DRbK225/SteD) (Stu-
dent’s t test p < 0.03, comparison between DRb/
SteD and DRbK225/SteD). Double asterisks in
(C)–(E) denote di-ubiquitinated DRb.
(F) Surface levels of mMHCII on stable cells
described in (E), measured by mAb L243 labeling
and flow cytometry. The data shown are surface
levels of mMHCII relative to that in cells ex-
pressing HA-DRb. ***p < 0.001, **p < 0.01, and
not significant, ns (Student’s t test). The data
shown are surface levels of mMHCII relative to
that in cells expressing HA-DRb.
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Figure 4. Interactions between SteD,
MARCH8, and mMHCII
(A) Flow cytometry analysis of Mel Juso cells that
were treated with siRNA prior to infection withWT-
GFP Salmonella. The data represent surface levels
of mMHCII in infected cells as a percentage of
those in uninfected cells from the same sample
and are the means ± SD from three independent
experiments.
(B) Mel Juso cells transduced with shRNA to
knockdown MARCH8 or a scramble control were
infected at an MOI of 300:1 and at 16 hr post in-
vasion lysed for immunoprecipitation with mAb
L243 followed by western blot analysis with anti-
ubiquitin (P4D1-HRP) and anti-DRa. sh MARCH8
and sh scramble images after immunoprecipita-
tion (IP) are from the same blot and exposure.
(C) HEK293T cells transfected with vectors ex-
pressing MARCH8-FLAG and GFP-SteD or GFP
alone were used for immunoprecipitation with
GFP-Trap beads. () indicates MARCH8-FLAG
alone. The immunoprecipitates were analyzed by
western blot using anti-GFP and anti-FLAG anti-
bodies.
(D) Stable Mel Juso cells expressing GFP-SteD
and MARCH8-FLAG were analyzed by immuno-
fluorescence with anti-FLAG (red) and mAb L243
against mMHCII (gray), the arrows indicate vesi-
cles in which the three proteins co-localized. The
scale bar represents 5 mm.
(E) Stable Mel Juso cell lines expressing both
MARCH8-FLAG and GFP-SteD or MARCH8-
FLAG and GFP alone were used for immunopre-
cipitation with mAb L243 (for mMHCII) or isotype
control. The immunoprecipitates were analyzed
by western blot using anti-GFP, anti-FLAG, and
anti-DRa antibodies. The samples in (A) were
compared to siRNA scramble by one-way ANOVA
followed by Dunnett’s multiple comparison test.
**p < 0.01 and not significant, ns.contained GFP-SteD, but not the GFP control (Figure 4D). To
investigate physical interactions between SteD, MARCH8, and
mMHCII in these cells, mMHCII was immunoprecipitated with
mAb L243. mMHCII interacted with GFP-SteD, but not with
GFP (Figure 4E). It also interacted with MARCH8-FLAG in the
presence or absence of SteD (Figure 4E). Live cell imaging anal-
ysis of Mel Juso cells expressing mCherry-MARCH8 and GFP-
SteD revealed that both proteins were often present in the
same vesicles, moving in both anterograde and retrograde direc-
tions (Movie S2; Figures S2C and S2D).
To identify regions of SteD that are important for interacting
with mMHCII and MARCH8, we first constructed truncatedCell Host & Micversions lacking either the N-terminal
or C-terminal cytoplasmic domains. The
amount of the N-terminal SteD mutant
fused to GFP was much lower than that
of the wild-type fusion protein, preventing
analysis of its properties. However, a
version lacking the C-terminal 11 amino
acids (GFP-SteDCt) was expressed nor-
mally. GFP-SteDCt also integrated intohost cell membranes (Figure S3A), interacted with MARCH8-
FLAG(Figure5A),buthad reducedbinding tomMHCII (Figure5B).
In infected cells, SteDCt induced weak ubiquitination of mMHCII
(Figure 5C), and after transfection it caused significantly less
reduction of mMHCII surface levels (Figure 5D). A more detailed
mutational analysiswascarried out bymaking a series of 20 small
alanine substitutions (SteD1–SteD20) in blocks of five or six amino
acids, to cover the entire sequence of SteD (Figure 5E). These
variants were tagged with GFP and analyzed after transfection
to circumvent any defects in their translocation from bacteria.
There were two mutants (SteD9 and SteD13) that were unstable
and did not localize at the Golgi network (Figures S4A androbe 20, 584–595, November 9, 2016 589
Figure 5. Mutational Analysis of SteD
(A) HEK293T cells transfected with vectors expressing
MARCH8-FLAG and GFP, GFP-SteD, or GFP-SteDCt
were used for immunoprecipitation with GFP-Trap
beads and analyzed by western blot with anti-GFP and
anti-FLAG antibodies.
(B) Stable Mel Juso cell lines expressing GFP, GFP-
SteD, and GFP-SteDCt were used for immunoprecipi-
tation with mAb L243 (for mMHCII). The immunopre-
cipitates were analyzed by western blot with anti-GFP
and anti-DRa antibodies. The blot shown is represen-
tative of three separate experiments in which the mean
intensity of GFP-SteDCt compared to GFP-SteD after
immunoprecipitation was 0.21 ± 0.14 (p < 0.02).
(C) Mel Juso cells were infected at an MOI of 300:1 and
at 16 hr post invasion lysed for immunoprecipitation
with mAb L243 followed by western blot analysis with
anti-ubiquitin (P4D1-HRP) and anti-DRa antibodies.
(D) Mel Juso cells were transfected with vectors en-
coding GFP, GFP-SteD, and GFP-SteDCt, andmMHCII
surface levels were analyzed by flow cytometry. The
data represent surface levels of mMHCII in transfected
cells as a percentage of those in untransfected cells
from the same sample and are the means ± SD from
three independent experiments.
(E) Schematic representation of SteD amino acids
substituted with alanine. The transmembrane regions
are shaded in gray.
(F) Mel Juso cells were transfected with vectors en-
coding mutated versions of SteD fused to GFP, and
mMHCII surface levels were analyzed by flow cy-
tometry. The data were analyzed as for (D) above.
(G) Stable Mel Juso cell lines expressing GFP, GFP-
SteD, GFP-SteD6, or GFP-SteD16 were lysed and mAb
L243 was used for immunoprecipitation and analysis
as in (C).
(H) The stable cells used in (G) were used for immu-
noprecipitation with mAb L243 (for mMHCII) and
analyzed as in (B).
(I) HEK293T cells transfected with vectors expressing
MARCH8-FLAG and GFP, GFP-SteD, GFP-SteD6, or
GFP-SteD16 were used for immunoprecipitation with
GFP-Trap beads and analyzed as in (A). The blot shown
is representative of three separate experiments in
which the mean intensity of GFP-SteD16 compared to
GFP-SteD after immunoprecipitation was 0.12 ± 0.07
(p < 0.02). The data in (D) and (F) were compared to
GFP-SteD by one-way ANOVA followed by Dunnett’s
multiple comparison test. ****p < 0.0001, ***p < 0.001,
**p < 0.01, and not significant, ns.
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S4B). Expression and localization of the remaining 18 GFP-SteD
mutants were similar to wild-type SteD (Figures S4A and S4B).
Measurement of mMHCII surface levels in cells producing these
mutants revealed several regions that are important for SteD
function (Figure 5F). The two mutants having the weakest effect
on mMHCII surface levels were SteD6 and SteD16; in both cases
thiswas accompanied by reduced ubiquitination ofmMHCII (Fig-
ure 5G). SteD6 and SteD16 integrated into host cell membranes
(Figures S3B and S3C) and were not impaired in their ability to
interact with mMHCII (Figure 5H). By contrast, in HEK293T cells,
SteD16, but not SteD6, failed to interact efficiently with MARCH8-
FLAG (Figure 5I). Together, themutational analysis ofSteDshows
that the C-terminal 11 amino acids and second transmem-
brane domain are important for interactions with mMHCII and
MARCH8, respectively. Furthermore, although SteD6 interacted
with bothmMHCII andMARCH8, it failed to induce ubiquitination
and removal of surface mMHCII, which suggests that SteD has
additional function(s) in regulating MARCH8-dependent ubiquiti-
nation of mMHCII.
SteD-Mediated Reduction of Surface mMHCII Affects
T Cell Proliferation
EfficientMHCII-dependentTcell activation requires recognitionof
both peptide-loaded mMHCII and the co-stimulatory molecule
CD86/B7.2, whose surface level is also regulated by MARCH8/1
ubiquitination (Barteeet al., 2004;Gotoet al., 2003).Weconfirmed
that WT Salmonella reduced overall mouse MHCII (I-A/I-E haplo-
types) surface levels in bone marrow-derived DCs (BMDCs) and
showed that the reduction did not occur in BMDCs infected with
DssaVorDsteDmutants (Figure6A).BMDCs infectedwithWTSal-
monellaalsodisplayed reduced surface levels ofB7.2, and this ef-
fect was lost following infection with the DssaV or DsteDmutants
(Figure 6B). To assess the effect of SteD on T cell proliferation, in-
fected BMDCs were incubated with Ovalbumin (OVA)-peptide at
16 hr post uptake, co-cultured for 3 days with T cells expressing
a T cell receptor specific for OVA, and labeled with carboxyfluor-
escein diacetate succinimidyl ester (CFSE) to determine T cell
proliferation by flow cytometry. WT Salmonella induced a strong
SteD-dependent inhibition of T cell proliferation (Figures 6C and
6D), consistent with its effect on both mMHCII and CD86/B7.2.
To determine if SteD influencesMHCII surface levels during infec-
tion of mice, DCs were isolated at 48 hr post oral inoculation from
mesenteric lymph nodes. Quantification of total surface MHCII
(I-A/I-E) by flow cytometry revealed that DCs infected by
the WT-GFP strain had significantly reduced levels of MHCII
compared to DCs infected with the DsteD-GFP strain (Figures
6E and S5E). Finally, to assess the effect of SteD on T cell activa-
tion in vivo,micewere infected for 17dayswithWTor steDmutant
Salmonella, then spleencellswere recoveredandTcells analyzed
for activation markers by flow cytometry. Analysis of CD4+ T cells
from mice with similar bacterial loads revealed that there were
significantly more activated T cells in spleens carrying the steD
mutant compared to spleens frommice infectedwithWTbacteria
(Figures 6F and S5F).
DISCUSSION
Numerous bacterial effectors have been characterized that inter-
fere with distinct aspects of the mammalian innate immune sys-tem (McGuire and Arthur, 2015), but much less is known about
effectors that inhibit the development of adaptive immunity.
Several groups have shown that Salmonella inhibits surface pre-
sentation of MHCII (Cheminay et al., 2005; Halici et al., 2008;
Jackson et al., 2013; Lapaque et al., 2009a; Mitchell et al.,
2004). This was attributed to the SPI-2 T3SS (Cheminay et al.,
2005; Mitchell et al., 2004) and the actions of several effectors
that interfere with vesicular trafficking (Cheminay et al., 2005;
Halici et al., 2008). Lapaque et al. (2009a) showed that Salmo-
nella specifically reduces the surface levels of mMHCII through
its ubiquitination. Several possible mechanisms were proposed
to account for this, including delivery of a Salmonella ubiquitinat-
ing enzyme and the relocalization of mMHCII or host ubiquitin
enzymes to facilitate their interactions (Lapaque et al., 2009a).
The results presented here, showing that SteD interacts directly
or indirectly with bothMARCH8 andmMHCII, are consistent with
the latter proposal. These interactions might occur in a binary
manner, with some SteD molecules interacting with mMHCII
and others with MARCH8. However, mutational analysis re-
vealed two distinct regions of SteD that are important for sup-
pressing surface levels of mMHCII: the cytoplasmic C-terminal
11 amino acids are involved in binding mMHCII and part of the
second transmembrane domain is important for binding to
MARCH8. Both regions are also required for ubiquitination and
reduced surface load of mMHCII. This suggests that SteD func-
tions as an adaptor, facilitating interactions between enzyme
and substrate. The finding that a transmembrane region of
SteD is required for efficient binding to MARCH8 is consistent
with other work showing transmembrane domain-dependent
recognition of proteins by MARCH1 and MARCH8 (Fujita et al.,
2013; Goto et al., 2003) and, more generally, the existence of
several integral membrane ubiquitin ligase adaptors that regu-
late E3 ligase/substrate interactions (Le´on andHaguenauer-Tsa-
pis, 2009).
Two results indicate that SteD has additional function(s). First,
in Mel Juso cells, similar amounts of MARCH8 interacted with
mMHCII in the presence or absence of SteD. Second, the
SteD6 mutant was defective in ubiquitinating and reducing sur-
face levels of mMHCII, yet retained binding to MARCH8 and
mMHCII. This indicates that SteD might also activate MARCH8,
which is interesting in light of other evidence suggesting the ex-
istence of an endogenous cofactor for MARCH8 (Fujita et al.,
2013). Thus, SteD might mimic the activity of an as yet unidenti-
fied mammalian membrane adaptor/cofactor that functions with
MARCH1/8 to provide substrate specificity and regulate E3
ligase activity.
The finding that the majority of SteD locates to the TGN raises
interesting questions regarding its transport from the SCV, Golgi
membrane insertion, and the significance of Golgi localization.
A substantial amount of MARCH8 co-localized with non-Golgi
associated SteD, and vesicles containing both proteins were
observed moving throughout the host cell (Figures S2C and
S2D). Since mMHCII does not traffic to the Golgi network
(Neefjes et al., 2011), the simplest hypothesis is that SteD inter-
acts with MARCH8 in Golgi membranes or Golgi-derived vesi-
cles, and the proteins are then transported to endosomes and
possibly to the plasma membrane to interact with mMHCII.
Cho et al. (2015) showed that in immature mouse DCs, MARCH1
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Figure 6. SteD Suppresses T Cell Prolif-
eration
(A) Mouse BMDCs were infected with the indi-
cated bacterial strains and total MHCII surface
levels (I-A/I-E haplotypes) were quantified by flow
cytometry at 20 hr post uptake.
(B) BMDCs were infected as in (A), and B7.2 sur-
face levels were quantified by flow cytometry at
20 hr post uptake.
(A and B) Surface levels of proteins in infected
cells are represented as a percentage of those in
uninfected cells from the same sample and are the
means ± SD from four independent experiments.
(C) Infected BMDCs were incubated with OVA
peptide and co-cultured with T cells labeled with
CFSE for 3 days. T cell proliferation was analyzed
by flow cytometry after labeling cells with anti-
CD3, anti-V alpha2, and anti-CD4 antibodies. The
uninfected BMDCs incubated or not with OVA-
peptide were used as controls. The results shown
represent the% of T cells that proliferated and are
the means ± SD from quadruplicate samples in
three independent experiments.
(D) Representative FACS histograms showing
T cell proliferation measured by CFSE levels in
different conditions.
(E) Dendritic cells frommesenteric lymph nodes of
mice infected with WT-GFP or DsteD-GFP Sal-
monella by oral gavage were isolated at 48 hr post
inoculation and total MHCII surface levels were
measured by flow cytometry. The data represent
surface levels of MHCII in infected BMDCs as a
percentage of those in uninfected cells from the
same sample and are the means ± SD from three
independent experiments.
(F) Activated T cells (CD25+CD44+ and CD62L
CD44+) as a percentage of total CD4+ T cells
isolated from the spleens of mice infected by
Salmonella WT or DsteD strains at day 17 post
inoculation. The data in (A) and (B) were analyzed
by comparison with WT and in (C) by comparison
with uninfected +OVA by one-way ANOVA fol-
lowed by Dunnett’s multiple comparison test. The
data in (E) were analyzed by Student’s t test. The
data in (F) were analyzed by two-tailed pairwise
t test using pairs shown in Table S2. ****p < 0.0001,
**p < 0.01, *p < 0.02, and not significant, ns.prevents its recycling to the plasma membrane from intracellular
vesicles. Ubiquitination of mMHCII by MARCH1 in early endo-
somes promotes its sorting into multivesicular bodies and lyso-
somal degradation (Cho et al., 2015; Furuta et al., 2013). The
presence of SteD and MARCH8 on intracellular vesicles sug-
gests that its effect on mMHCII is to prevent recycling to the
plasma membrane, but further work is needed to establish if
SteD also acts on the plasma membrane pool of mMHCII.
Whereas the effect of SteD on DC surface MHCII (Figure 6A)
appears relatively modest, the inhibition of T cell proliferation
was very dramatic (Figure 6C). However, the antibody used to
detect surface MHCII on DCs does not discriminate between
mMHCII and Ii-MHCII forms and therefore is likely to underesti-
mate the effect of SteD on mMHCII in this assay. Furthermore,
we found that SteD also reduces surface levels of the co-stimu-592 Cell Host & Microbe 20, 584–595, November 9, 2016latory molecule CD86/B7.2, which is also regulated by MARCH1
(Bartee et al., 2004) and required for full T cell activation. Whether
this results from a similar mechanism to that of SteD on mMHCII
remains to be determined, but the combined effect of SteD on
both mMHCII and CD86/B7.2 provides an explanation for its
potent effect on T cell activation (Figure 6C).
MARCH1 expression was reported to be restricted to second-
ary lymphoid tissues, while MARCH8 is ubiquitously expressed
(Bartee et al., 2004). In immature DCs, the expression of
MARCH1 is relatively high, enabling it to prevent mMHCII from
recycling to the cell surface, but its expression is reduced by
over 90% following DC activation (Cho et al., 2015; De Gassart
et al., 2008). Conversely, MARCH8 expression remains un-
changed during the maturation process (De Gassart et al.,
2008) and functions in transferrin receptor recycling (Fujita
et al., 2013), but does not seem to contribute to recycling of
mMHCII. It is possible that SteD diverts MARCH8 from its normal
function or activity to increase ubiquitination of mMHCII in
mature DCs after Salmonella infection. However, we did not
detect a difference in overall surface levels of transferrin receptor
in DCs infected withWT or steDmutant bacteria (Figure S5G), so
the identity of the MARCH ligase targeted by SteD in DCs re-
mains to be established.
SteD accounted for potent inhibition of T cell proliferation by
Salmonella in vitro. In vivo, DCs from mouse mesenteric lymph
nodes infected with the WT bacteria displayed less cell surface
MHCII than DCs infected with the steD mutant. Furthermore,
we detected a significant SteD-dependent suppression of
T cell activation in spleens of mice infected with Salmonella.
Therefore, the in vitro effects of SteD on mMHCII and T cells
are likely to be physiologically important. Several bacterial path-
ogens, including Salmonella, encode ubiquitin ligases that target
host cell proteins (Ashida et al., 2014). We show here the exis-
tence of a distinct mechanism, by which a bacterial effector
binds and possibly activates a host E3 ligase to force the inap-
propriate ubiquitination of a substrate. SteD appears to be the
first example of a bacterial protein that targets mMHCII to sup-
press adaptive immune responses. In view of the critical role of
MHCII molecules in the development of adaptive immunity to
many bacteria, it is possible that other pathogens might use
similar mechanisms to promote their virulence.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Antibodies
All bacterial strains, plasmids, and antibodies used in this study are described
in Table S1. Isogenic mutants of S. enterica serovar Typhimurium were con-
structed using one-step chromosomal inactivation system (Datsenko and
Wanner, 2000). Wild-type and mutant strains were transformed with plasmids
pFPV25.1 and pFCcGi for GFP and mCherry expression, respectively, when
required.
Cell Culture and Infection
Mel Juso and HEK293T cells were maintained in DMEM containing 10% fetal
calf serum (FCS) at 37C in 5% CO2. L243-producing hybridoma cells were
maintained in DMEM containing 10% FCS and reduced to 5% FCS when
cell density was high to harvest supernatant containing antibodies. Primary
BMDCs were extracted from C57BL/6 mice (Charles River). Cells recovered
from tibias and femurs were grown at 37C in 5% CO2 in RPMI-1640 supple-
mented with 10% FCS, 2 mM glutamine, 1 mM sodium pyruvate, 10 mM
HEPES, 0.05 M b-mercaptoethanol, and 20 ng/mL granulocyte-macrophage
colony-stimulating factor (GM-CSF) (PeproTech). After 3 days of culture, fresh
complete medium was added to the growing cells. On day 6, medium was re-
placed by fresh complete medium, and cells were harvested on day 8 and
seeded 6 hr prior to infection. Bacteria were grown in Luria Bertani (LB) me-
dium with shaking at 37C, supplemented with carbenicillin or kanamycin as
required (50 mg/mL). Mel Juso cells were infected for 30 min at MOI of 100:1
with late log-phase Salmonella. BMDCs were infected for 30 min at MOI
10:1 with stationary-phase Salmonella opsonized in 20% mouse serum. Cells
were washed with PBS twice and incubated in freshmedium containing genta-
micin (100 mg/mL) for 1 hr to kill extracellular bacteria. After 1–2 hr, the anti-
biotic concentration was reduced to 20 mg/mL, and the cells were processed
16–20 hr post uptake. Approximately 70% of Mel Juso cells and BMDCs
became infected using these conditions.
siRNA and DNA Transfection and Retroviral Transduction
Details of siRNA and shRNA transfection are in the Supplemental Information.
Knock down of MARCH8 and MARCH9 mRNA was assessed by qPCR using
SYBR GREEN and conditions described previously (Lapaque et al., 2009a).DNA transfection procedures were carried out using Lipofectamine 2000
according to the manufacturer’s protocol (Life Technologies). Samples were
prepared for analysis 20 hr after transfection. For retrovirus production,
HEK293T cells were transfected with proviral plasmid M5P together with
helper plasmids using Lipofectamine 2000 as described previously (Randow
and Sale, 2006). Mel Juso cells were transduced with virus in culture superna-
tant containing 8 mg/mL polybrene (Sigma-Aldrich) by centrifugation at 650 g
for 1 hr at 37C. Transduced cells were selected in 2 mg/mL puromycin or
GFP-positive cells were sorted by fluorescence-activated cell sorting (FACS)
as required.
Flow Cytometry
To measure surface levels of mMHCII, Mel Juso cells that had been either
transfected or infected with Salmonella were collected using Cell Dissociation
Buffer (Sigma-Aldrich) and incubated first with mAb L243 and then anti-mouse
secondary antibody diluted in FACS buffer (5%FCS and 2mMEDTA in PBS) at
4C for 30 min. After washings with cold PBS, cells were fixed in 3% parafor-
maldehyde and analyzed using a FACS Calibur or Fortessa flow cytometer
(BD Biosciences) and FlowJo v10 software. mMHCII surface levels were
calculated as geometric mean fluorescence of infected cells (GFP-positive)/
geometric mean fluorescence of uninfected cells (GFP-negative) 3 100. For
complementation analysis of bacterial mutants, Mel Juso cells were infected
with non-fluorescent bacterial strains and, after labeling of surface mMHCII,
cells were fixed and incubated with anti-Salmonella CSA-1 antibody diluted
in 10% FCS and 0.1% saponin in PBS for 1 hr at room temperature, followed
by anti-goat secondary antibody labeling under the same conditions. Surface
levels of MHCII or B7.2 in BMDCs were calculated as median fluorescence of
infected cells (CSA1-positive)/median fluorescence of uninfected cells (CSA1-
negative) 3 100. For the internalization assay, Mel Juso cells were infected
with WT-GFP or DsteD-GFP Salmonella strains and harvested 16 hr post inva-
sion. The surfacemMHCII molecules were labeled with mAb L243 for 30min at
4C. Cells were washed in cold medium, resuspended, and split into 1.5 mL
tubes containing pre-warmed medium in a water bath at 37C. Aliquots
were removed at various time points, diluted in ice-cold FACS buffer, and
kept on ice. At the last time point, cells were centrifuged at 4C and resus-
pended in FACS buffer containing Alexa 647-conjugated goat anti-mouse anti-
body. After 30 min at 4C, cells were washed, fixed in 3% paraformaldehyde,
washed, and analyzed by flow cytometry to quantify mMHCII/L243 complexes
remaining at the cell surface. GFP-positive cells were considered infected and
GFP-negative uninfected. mMHCII surface levels were normalized to those
detected at the beginning of the experiment (100%).
Immunofluorescence Microscopy
Cells were fixed and immunolabeled with antibodies listed in Table S1. Sam-
ples were mounted and analyzed using a confocal laser-scanning microscope
LSM 710 (Zeiss). Co-localization analysis was done with Zeiss Zen 710 soft-
ware, with thresholds set using individual controls lacking each analyzed
primary antibody. Further details are in Supplemental Information.
Membrane Fractionation
Approximately 5 3 107 Mel Juso cells were infected as described above. At
20 hr post invasion, cells were collected and lysed by mechanical disruption
using a Dounce homogenizer in 600 mL of homogenization buffer containing
250 mM sucrose, 3 mM imidazole (pH 7.4), and 1 mM PMSF. Cell extracts
were centrifuged at 1,800 g for 15 min and the post nuclear supernatant was
centrifuged at 100,000 g for 1 hr at 4C, giving rise to a pellet containing total
membrane proteins and supernatant containing soluble proteins. The pellet
was resuspended in 600 mL of 2.5 M urea and incubated for 15 min on ice.
This suspension was centrifuged again at 100,000 g for 1 hr at 4C, resulting
in a second pellet containing integral membrane proteins and a supernatant
containing membrane-associated proteins. The volume of all fractions was
made to 600 mL with homogenization buffer, and proteins were analyzed by
western blot.
Immunoprecipitation and Western Blot
Analysis of mMHCII ubiquitination was done as described previously with
minor modifications (Lapaque et al., 2009a). Further details are in Supple-
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Live Imaging
For live cell imaging, Mel Juso cells stably expressing GFP-SteD were seeded
at a density of approximately 53 104 cells per dish onto 35 mm glass-bottom
culture dishes (MatTek). Cells were transfected for 20 hr with a vector express-
ing mCherry-MARCH8 using Lipofectamine 2000 (Life Technologies) following
manufacturer’s instructions. Before imaging, cells werewashed and incubated
in imaging medium (Opti-MEM containing 10% FCS and 25 mM HEPES
pH 7.2). Culture dishes were sealed with vaseline and analyzed using a LSM
710 microscope (Zeiss) at 37C. Samples were imaged with a 63 3 oil
objective.
T Cell Proliferation Assay
BMDCs were prepared from C57BL/6 mice as described above. The CD11c-
positive cell population was enriched using MAC sorting (Miltenyi Biotec) to a
purity of 95%. Cells were infected in 15 mL tubes at an MOI 10:1 for 30 min in
RPMI 10% FCS, washed, and treated with gentamicin as described above.
After 16 hr of infection, cells were harvested with cold PBS and incubated
with OVA peptide (ISQAVHAAHAEINEAGR) at 5 mM in RPMI containing
10% FCS for 1 hr. Cells were washed, counted, and incubated with T cells
in 96-well plates. T cells expressing OVA-specific T cell receptor (TCR)
were isolated from cell suspensions of spleens and lymph nodes of OT-II
mice by magnetic sorting of CD4+ cells (Miltenyi Biotec) and labeled with
CFSE as described previously (Quah and Parish, 2010). CD4 T cells were
incubated with DCs at a ratio of 3:1 in a final volume of 200 mL of medium con-
taining 20 mg/mL gentamicin. At 3 days later, cells were centrifuged and re-
suspended in 150 mL of FACS buffer containing anti-CD3, anti-V alpha2,
and anti-CD4 antibody and incubated for 30 min on ice. Cells were washed
and resuspended in 150 mL of FACS buffer containing 6 mm blank calibration
particles (BD Biosciences) as an internal control for normalization of T cell
numbers.
Mouse Infection and Isolation of DCs
Female C57BL/6 mice, 6–8 weeks old, were infected by oral gavage with
1 3 1010 colony forming units (CFU) of late log-phase GFP-Salmonella in
200 mL of PBS containing 3%NaHCO3. Mesenteric lymph nodes were isolated
48 hr after inoculation and cells were collected through a 70 mm cell strainer
following tissue disruption. DCs were purified from single-cell suspensions
using anti-CD11c antibody-coupled magnetic beads (Miltenyi Biotec) accord-
ing to the manufacturer’s instructions. Purified DCs were labeled on ice with
anti-I-A/I-E antibody (recognizing mouse MHC class II molecules), diluted in
FACS buffer for 20 min on ice. Purity was assessed by anti-CD11c antibody
labeling. Discrimination between infected and uninfected cells was based on
GFP fluorescence and MHCII geometric mean fluorescence calculated as
described above. For analysis of T cell activation, mice were inoculated intra-
peritoneally with 5 3 105 CFU of virulence-attenuated S. Typhimurium strain
SL3261 or SL3261 DsteD that had been grown in LB broth to late exponential
phase. Spleens were harvested 17 days later and homogenized in Hanks
balanced salt solution (HBSS) supplemented with 10 mM HEPES and 2%
FCS. A portion of spleen homogenate was plated to enumerate bacterial
CFU and spleens with similar bacterial loads (Table S2) were analyzed further.
Erythrocytes were lysed using ACKbuffer (150mMNH4Cl, 10mMKHCO3, and
0.1 mM EDTA). After blocking surface Fc receptors using FcR Blocking
Reagent (Miltenyi Biotec), the remaining splenocytes were labeled using
anti-CD3ε, anti-CD4, anti-CD25, anti-CD44, and anti-CD62L antibodies. Acti-
vation of gated CD4+CD3ε+ cells was determined on the basis of surface-local-
ized CD25, CD62L, and CD44.
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